- $17.49m
- $104.13m
- $107.88m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:36 AM
NASDAQ RESUMED AT 11:28 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:23 AM
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
NASDAQ RESUMED AT 09:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
MDxHealth SA reports results for the quarter ended June 30 - Earnings Summary
MDxHealth SA expected to post a loss of 19 cents a share - Earnings Preview
Brief: Mdxhealth Reports Q1-2026 Results
Brief: Mdxhealth Reports Preliminary Fourth Quarter And Full Year 2025 Revenues, Issues 2026 Revenue Guidance, And Amends Earnout Terms With Exact Sciences
Brief: MDxHealth SA - To Offer Securities Up To $200 Million - SEC Filing
Brief: Mdxhealth Announces Closing Of Exosome Diagnostics Acquisition From Bio-Techne
MDxHealth SA reports results for the quarter ended June 30 - Earnings Summary
MDxHealth SA expected to post a loss of 11 cents a share - Earnings Preview
Bio-Techne beats quarterly estimates, flags tariff uncertainty for customers (updated)
Bio-Techne beats quarterly estimates on strength in protein sciences unit
MDxHealth SA reports results for the quarter ended March 31 - Earnings Summary
MDxHealth SA expected to post a loss of 13 cents a share - Earnings Preview